Clinical Approach to Lower Gastrointestinal Bleeding
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of lower gastrointestinal bleeding
Lower gastrointestinal bleeding (LGIB) accounts for approximately 20-25% of all gastrointestinal hemorrhage cases and results in over 300,000 hospital admissions annually in the United States. While historically considered less severe than upper gastrointestinal bleeding, LGIB carries a mortality rate of 2-4% overall, rising to 10-20% in hospitalized patients with significant comorbidities. The incidence increases dramatically with age, with rates more than 200 times higher in patients over 80 years compared to those under 20 years. Approximately 80-85% of LGIB episodes resolve spontaneously, but 15-20% require intervention, and rebleeding occurs in 10-40% of cases depending on the underlying etiology.
Definition
Lower gastrointestinal bleeding is defined as hemorrhage originating distal to the ligament of Treitz, which marks the junction between the duodenum and jejunum. This encompasses bleeding from the small intestine (jejunum and ileum), colon, rectum, and anus. Clinically, it typically presents as hematochezia (passage of fresh or altered blood per rectum), though slow lower gastrointestinal bleeding may occasionally present as melena if colonic transit time is prolonged. The term “overt” LGIB refers to visible bleeding, while “occult” LGIB refers to bleeding detected only by fecal occult blood testing or iron deficiency anemia.
Classification by Severity
| Severity | Clinical Criteria | Management Setting | Typical Outcomes |
|---|---|---|---|
| Mild | Hemodynamically stable, hemoglobin drop less than 2 g/dL, no transfusion required | Outpatient or observation | Self-limited in more than 90% of cases |
| Moderate | Stable vital signs but hemoglobin drop 2-4 g/dL, may require 1-2 units transfusion | Inpatient ward | Most resolve with supportive care |
| Severe | Hemodynamic instability (systolic blood pressure less than 90 mmHg or heart rate greater than 100), hemoglobin drop greater than 4 g/dL, or requiring greater than 2 units transfusion | Intensive care unit | Requires urgent intervention in 15-20% |
| Massive | Requiring greater than 4 units transfusion in 24 hours, persistent hemodynamic instability despite resuscitation | Intensive care with surgical standby | High mortality (10-20%), often requires surgery or angioembolization |
Classification by Anatomical Source
Colonic Sources (90-95%)
The vast majority of lower gastrointestinal bleeding originates from the colon. Common sources include diverticulosis (responsible for 30-40% of cases), colonic angiodysplasia (also called arteriovenous malformations), colorectal neoplasia, inflammatory bowel disease, and ischemic colitis. The right colon is disproportionately affected in diverticular bleeding and angiodysplasia, while left-sided sources are more common in ischemic colitis and neoplasia.
Small Bowel Sources (5-10%)
Small bowel bleeding is less common but diagnostically challenging. Causes include angiodysplasia (the most common small bowel source), small bowel tumors, Meckel diverticulum (particularly in younger patients), Crohn disease, and nonsteroidal anti-inflammatory drug-induced enteropathy. Small bowel sources should be suspected when both upper endoscopy and colonoscopy are negative.
Classification by Clinical Presentation
| Presentation | Description | Suggests |
|---|---|---|
| Bright red blood per rectum (hematochezia) | Fresh red blood, may be mixed with stool or occur independently | Distal colonic or anorectal source; brisk upper gastrointestinal bleeding if massive |
| Maroon-colored stool | Dark red or burgundy-colored stool | Right colonic or small bowel source; rapid transit upper gastrointestinal bleeding |
| Blood-streaked stool | Normal stool with blood on surface | Anorectal source (hemorrhoids, fissure, rectal lesion) |
| Blood mixed with mucus | Bloody mucoid discharge | Inflammatory bowel disease, infectious colitis, colorectal malignancy |
| Melena with negative upper endoscopy | Black tarry stool without upper source | Proximal small bowel source, slow right-sided colonic bleeding |
| Occult bleeding | Positive fecal occult blood test without visible blood | Colorectal neoplasia, angiodysplasia, any slow-bleeding source |
Classification by Temporal Pattern
| Pattern | Duration and Course | Common Etiologies |
|---|---|---|
| Acute single episode | Self-limited bleeding lasting hours to days | Diverticular bleeding, hemorrhoidal bleeding, post-polypectomy bleeding |
| Acute recurrent | Multiple discrete bleeding episodes over weeks to months | Diverticulosis (20-30% rebleed), angiodysplasia, neoplasia |
| Chronic intermittent | Episodic minor bleeding over months to years | Hemorrhoids, inflammatory bowel disease, colorectal polyps or cancer |
| Chronic continuous | Persistent low-grade blood loss causing iron deficiency anemia | Colorectal malignancy, angiodysplasia, radiation proctitis |
The “Rule of Eighty” for Diverticular Bleeding: Diverticulosis is present in approximately 80% of individuals over age 80, yet only about 3-5% of those with diverticulosis will ever experience bleeding. However, when diverticular bleeding does occur, it is the single most common cause of acute lower gastrointestinal bleeding in adults, accounting for 30-40% of cases. Despite the preponderance of left-sided diverticula in Western populations, right-sided diverticula are more prone to bleeding due to the wider necks and larger vasa recta penetration in the right colon.
Age-Related Distribution of Causes
| Age Group | Most Common Causes | Important Considerations |
|---|---|---|
| Young adults (18-40 years) | Hemorrhoids, anal fissure, inflammatory bowel disease, infectious colitis | Meckel diverticulum if recurrent; malignancy rare but rising incidence |
| Middle-aged adults (40-60 years) | Hemorrhoids, diverticulosis, colorectal polyps and cancer, inflammatory bowel disease | Screening colonoscopy important; colorectal cancer must be excluded |
| Older adults (greater than 60 years) | Diverticulosis, angiodysplasia, colorectal malignancy, ischemic colitis | Multiple etiologies often coexist; comorbidities affect management |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of lower gastrointestinal bleeding
Understanding the pathophysiology of lower gastrointestinal bleeding requires knowledge of the vascular anatomy of the gastrointestinal tract, the mechanisms by which different pathological conditions lead to hemorrhage, and the body’s hemostatic response to bleeding. The lower gastrointestinal tract has a rich blood supply derived primarily from the superior and inferior mesenteric arteries, with the watershed zones between vascular territories being particularly vulnerable to ischemic injury. The mechanism of bleeding varies considerably depending on the underlying etiology, ranging from arterial rupture in diverticular disease to capillary oozing in inflammatory conditions.
Vascular Anatomy of the Lower Gastrointestinal Tract
| Region | Blood Supply | Clinical Relevance |
|---|---|---|
| Jejunum and ileum | Superior mesenteric artery via jejunal and ileal branches with extensive arcades | Rich anastomotic network provides protection; angiodysplasia more common in ileum |
| Cecum and ascending colon | Superior mesenteric artery via ileocolic and right colic arteries | Larger vasa recta; higher propensity for diverticular bleeding and angiodysplasia |
| Transverse colon | Middle colic artery (superior mesenteric artery) | Variable anatomy; potential watershed area |
| Splenic flexure | Watershed zone between superior and inferior mesenteric artery territories | Most vulnerable to ischemic colitis; “Griffiths point” |
| Descending and sigmoid colon | Inferior mesenteric artery via left colic and sigmoid branches | Most diverticula located here; sigmoid volvulus risk |
| Rectum | Superior rectal (inferior mesenteric artery), middle and inferior rectal (internal iliac) arteries | Dual blood supply protects from ischemia; hemorrhoidal plexuses vulnerable |
| Rectosigmoid junction | Watershed zone; “Sudeck’s point” | Second watershed area; vulnerable in low anterior resection |
Mechanisms of Bleeding by Etiology
Arterial Rupture
Etiologies: Diverticular bleeding, Dieulafoy lesion, Meckel diverticulum
Mechanism: Direct erosion or rupture of an artery into the gastrointestinal lumen. In diverticulosis, the vasa recta penetrate the colonic wall at the dome of the diverticulum, making them vulnerable to injury from inspissated feces or mucosal trauma.
Clinical implication: Brisk, painless bleeding that is often massive but typically self-limited (80-85%). High rebleeding rate without intervention.
Vascular Ectasia
Etiologies: Angiodysplasia (arteriovenous malformations), radiation telangiectasia
Mechanism: Degenerative process where chronic low-grade obstruction of submucosal veins during muscular contraction leads to dilation and tortuosity. Over time, the capillary rings dilate, and arteriovenous communications develop.
Clinical implication: Typically chronic, intermittent, low-volume bleeding. Associated with aortic stenosis (Heyde syndrome) and von Willebrand disease.
Mucosal Inflammation
Etiologies: Inflammatory bowel disease, infectious colitis, radiation proctitis
Mechanism: Inflammatory mediators cause mucosal hyperemia, friability, and ulceration. In ulcerative colitis, continuous mucosal inflammation leads to superficial ulceration with capillary bleeding.
Clinical implication: Bloody diarrhea with mucus; bleeding usually low-volume but may be severe in fulminant colitis. Associated systemic symptoms present.
Ischemic Injury
Etiologies: Ischemic colitis, mesenteric ischemia, strangulated hernia
Mechanism: Reduced blood flow causes mucosal ischemia progressing to necrosis. The mucosa is most vulnerable, followed by submucosa, then muscularis. Watershed zones are preferentially affected.
Clinical implication: Sudden onset crampy abdominal pain followed by bloody diarrhea. May progress to full-thickness necrosis requiring surgery if transmural.
Neoplastic Invasion
Etiologies: Colorectal adenocarcinoma, polyps, gastrointestinal stromal tumors
Mechanism: Tumor outgrows blood supply causing central necrosis and ulceration, or tumor directly invades blood vessels. Polyp bleeding may occur from surface ulceration or traumatic avulsion.
Clinical implication: Typically chronic occult bleeding causing iron deficiency anemia, but may present acutely. Change in bowel habits and weight loss may accompany.
Mechanical Trauma
Etiologies: Post-polypectomy bleeding, anastomotic bleeding, rectal trauma
Mechanism: Direct injury to blood vessels from instrumentation or surgical intervention. Post-polypectomy bleeding occurs when the eschar at the polypectomy site sloughs, exposing underlying vessels.
Clinical implication: Bleeding typically occurs within 2 weeks of procedure; peak at days 5-7 for post-polypectomy bleeding. Usually self-limited but may require endoscopic therapy.
Detailed Pathophysiology by Condition
| Condition | Pathophysiological Mechanism | Treatment Implication |
|---|---|---|
| Diverticular bleeding | Vasa recta penetrate the colonic wall adjacent to diverticula, separated from the lumen only by mucosa. Chronic injury from inspissated feces causes asymmetric rupture of the artery into the diverticular sac. Bleeding is arterial and can be massive. | Endoscopic therapy (clips, coagulation) targets the bleeding vessel. Angiographic embolization if endoscopy fails. Segmental resection for recurrent bleeding from identified segment. |
| Angiodysplasia | Age-related degenerative process. Chronic venous obstruction during muscular contraction causes progressive dilation of submucosal veins, then venules and capillaries. Eventually, incompetent precapillary sphincters create arteriovenous communications with thin-walled, dilated vessels. | Endoscopic ablation (argon plasma coagulation). Medical therapy includes octreotide and estrogen-progesterone in selected cases. Treatment of associated conditions (aortic stenosis correction may reduce bleeding). |
| Ischemic colitis | Non-occlusive ischemia from low-flow states is most common. Watershed areas (splenic flexure, rectosigmoid junction) are vulnerable. Mucosal ischemia causes hemorrhagic necrosis; reperfusion injury may exacerbate damage. Progression to transmural necrosis occurs in 15-20% of cases. | Supportive care for non-gangrenous ischemia (bowel rest, intravenous fluids, broad-spectrum antibiotics). Emergent surgery for peritonitis, pneumatosis with portal venous gas, or clinical deterioration indicating transmural necrosis. |
| Inflammatory bowel disease | In ulcerative colitis, inflammatory infiltrate disrupts the mucosal barrier with crypt abscesses and superficial ulceration. In Crohn disease, transmural inflammation with deep fissuring ulcers can erode into mesenteric vessels. Severe bleeding is more common in Crohn disease. | Medical therapy (5-aminosalicylates, corticosteroids, biologics) controls inflammation and reduces bleeding. Surgery for refractory bleeding or toxic megacolon. Endoscopic therapy generally not effective for diffuse inflammation. |
| Colorectal malignancy | Tumor neovascularization creates abnormal, fragile vessels. Central tumor necrosis exposes vascular channels. Direct invasion of major vessels may cause massive hemorrhage. Right-sided tumors more commonly cause occult bleeding; left-sided tumors may cause visible bleeding. | Surgical resection is definitive treatment. Endoscopic hemostasis may temporize bleeding. Angiographic embolization for massive bleeding in unresectable disease. Palliative radiotherapy may reduce bleeding from rectal tumors. |
| Hemorrhoids | Hemorrhoidal cushions contain arteriovenous channels and connective tissue. Straining causes engorgement and downward displacement. Thinned mucosa over prolapsed internal hemorrhoids is susceptible to trauma, causing painless bright red bleeding from the arteriovenous shunts. | Conservative measures (fiber, stool softeners, sitz baths). Office-based procedures (rubber band ligation, sclerotherapy) for grades I-II. Hemorrhoidectomy for grade III-IV or failed conservative therapy. |
| Meckel diverticulum | Contains ectopic gastric mucosa in approximately 50% of symptomatic cases. Acid secretion from gastric mucosa causes ulceration of adjacent ileal mucosa, which may erode into the vascular supply. Bleeding is typically brisk and painless. | Meckel diverticulectomy or segmental ileal resection including the ulcer-bearing ileal segment. Technetium-99m pertechnetate scan localizes ectopic gastric mucosa. Surgery is curative. |
Often Overlooked Mechanism: Heyde Syndrome
Heyde syndrome describes the triad of aortic stenosis, acquired von Willebrand syndrome type 2A, and gastrointestinal bleeding from angiodysplasia. The high shear stress across the stenotic aortic valve causes cleavage of von Willebrand factor multimers, impairing primary hemostasis. This is clinically important because: (1) bleeding from angiodysplasia may resolve after aortic valve replacement, (2) patients with unexplained gastrointestinal bleeding should be screened for aortic stenosis, and (3) standard endoscopic therapy may be less effective without addressing the underlying coagulopathy. Consider checking von Willebrand factor activity in patients with recurrent angiodysplasia bleeding.
Hemostatic Response to Lower Gastrointestinal Bleeding
| Phase | Mechanism | Clinical Factors That Impair Hemostasis |
|---|---|---|
| Primary hemostasis | Vascular spasm and platelet plug formation at site of injury; requires adequate platelet count, function, and von Willebrand factor | Antiplatelet agents (aspirin, clopidogrel), thrombocytopenia, uremia, von Willebrand disease |
| Secondary hemostasis | Coagulation cascade activation leading to fibrin clot formation; stabilizes the platelet plug | Anticoagulants (warfarin, direct oral anticoagulants), liver disease, vitamin K deficiency, disseminated intravascular coagulation |
| Clot stabilization | Factor XIII cross-links fibrin; antifibrinolytic mechanisms prevent premature clot dissolution | Factor XIII deficiency, hyperfibrinolysis |
| Natural cessation | Most lower gastrointestinal bleeding stops spontaneously due to vasospasm, hypotension reducing perfusion pressure, and clot formation | Hypertension maintains perfusion pressure at bleeding site; continued anticoagulation; coagulopathy |
Why Location Matters: Right Versus Left Colonic Bleeding
Right Colon (Cecum to Hepatic Flexure)
Vascular anatomy: Larger vasa recta with wider diameters; less muscular wall
Common causes: Angiodysplasia (most common site), diverticular bleeding (despite fewer diverticula), cecal ulcers
Presentation: May present as melena if transit slow; often maroon or dark red blood
Surgical implication: Right hemicolectomy if source localized to right colon
Left Colon (Splenic Flexure to Rectum)
Vascular anatomy: Smaller caliber vessels; thicker muscular wall with higher intraluminal pressure
Common causes: Diverticular bleeding (most diverticula located here), ischemic colitis, colorectal malignancy
Presentation: Bright red blood per rectum; blood often seen on or mixed with stool
Surgical implication: Left or sigmoid colectomy; ischemic colitis often managed non-operatively
3. History Taking
A comprehensive approach to eliciting the lower gastrointestinal bleeding history
Red Flags — Require Urgent Evaluation
- Hemodynamic instability — Syncope, presyncope, tachycardia, hypotension suggest significant blood loss
- Large volume bright red blood per rectum — Suggests active arterial bleeding requiring urgent intervention
- Ongoing bleeding with anticoagulation — Higher risk of continued hemorrhage; may need reversal
- Severe abdominal pain with bleeding — Consider ischemic colitis, mesenteric ischemia, or perforation
- Peritoneal signs — Suggests transmural ischemia, perforation, or intra-abdominal catastrophe
- Age greater than 60 with new bleeding — Higher probability of malignancy and diverticular disease
- Unintentional weight loss with bleeding — Strongly suggests underlying malignancy
- Family history of colorectal cancer — Increases suspicion for neoplastic cause
Systematic History: The “BLEED” Approach
Use the mnemonic “BLEED” to ensure comprehensive history taking for lower gastrointestinal bleeding:
- B — Blood characteristics: What does the blood look like? Color (bright red, maroon, dark), amount, mixed with stool or on surface, clots present?
- L — Location and associated symptoms: Any abdominal pain (location, character)? Tenesmus? Urgency? Change in bowel habits? Diarrhea or constipation?
- E — Episodes and timing: When did it start? First episode or recurrent? How many episodes? Progressively worsening or stable? Previous similar episodes?
- E — Exacerbating and alleviating factors: Worse with straining? Related to meals? Related to bowel movements? Any recent procedures (colonoscopy, polypectomy)?
- D — Drugs and diseases: Anticoagulants, antiplatelets, NSAIDs? Known diverticulosis, inflammatory bowel disease, hemorrhoids, prior colorectal polyps or cancer? Liver disease, coagulopathy?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Diverticular bleeding | Sudden onset, painless, large volume, often right-sided source | “Did the bleeding start suddenly without any pain? Have you been told you have diverticulosis? Has this happened before?” |
| Angiodysplasia | Recurrent episodes, chronic anemia, older patient, associated cardiac disease | “Have you had multiple episodes of bleeding over months or years? Have you been told you are anemic? Do you have a heart murmur or aortic valve problem?” |
| Colorectal malignancy | Change in bowel habits, weight loss, blood mixed with stool, tenesmus | “Have you noticed any change in your bowel habits? Any unintentional weight loss? Is the blood mixed throughout the stool? Any sensation of incomplete evacuation?” |
| Inflammatory bowel disease | Bloody diarrhea, mucus, abdominal cramping, extraintestinal manifestations | “Do you have diarrhea with blood and mucus? Any joint pains, skin rashes, or eye problems? Family history of inflammatory bowel disease?” |
| Ischemic colitis | Sudden crampy abdominal pain followed by bloody diarrhea, older patient with vascular disease | “Did you have sudden abdominal pain before the bleeding started? Do you have heart disease, atrial fibrillation, or peripheral vascular disease? Any recent hypotensive episode or surgery?” |
| Infectious colitis | Acute bloody diarrhea, fever, recent travel or antibiotic use, food exposure | “Do you have fever or feel unwell? Any recent travel? Recent antibiotic use? Anyone else sick with similar symptoms? Any concerning food exposures?” |
| Hemorrhoids | Bright red blood on toilet paper or dripping into bowl, straining, perianal symptoms | “Is the blood bright red and seen on the toilet paper or dripping into the bowl? Do you strain with bowel movements? Any perianal itching, pain, or a lump you can feel?” |
| Anal fissure | Severe pain with defecation, bright red blood on paper, history of constipation | “Do you have severe pain during and after bowel movements? Is the blood bright red and in small amounts? Do you have hard stools or constipation?” |
| Post-polypectomy bleeding | Bleeding within 2 weeks of colonoscopy with polypectomy | “Have you had a colonoscopy recently? Were any polyps removed? When was the procedure? Did they mention the polyp size or use any special techniques?” |
| Radiation proctitis | History of pelvic radiation, chronic rectal bleeding, tenesmus | “Have you ever had radiation therapy to your pelvis? For what condition and when? Do you have persistent rectal bleeding with urgency?” |
Medication and Social History
Medications That Increase Bleeding Risk
- Anticoagulants — Warfarin, direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban), heparin, enoxaparin; significantly increase bleeding severity and duration
- Antiplatelet agents — Aspirin, clopidogrel, prasugrel, ticagrelor; impair primary hemostasis; dual antiplatelet therapy particularly high risk
- Nonsteroidal anti-inflammatory drugs — Ibuprofen, naproxen, diclofenac; cause mucosal injury and impair platelet function; including COX-2 selective inhibitors
- Selective serotonin reuptake inhibitors — Increase bleeding risk by depleting platelet serotonin; risk compounded with concurrent NSAID or antiplatelet use
- Corticosteroids — Impair mucosal healing; increase risk when combined with NSAIDs
Social and Past Medical History
- Alcohol use: Chronic use causes portal hypertension, coagulopathy, and increases risk of rectal varices and portal hypertensive colopathy
- Prior colonoscopy findings: Known diverticulosis, polyps, angiodysplasia, or inflammatory bowel disease; prior polypectomy sites
- Surgical history: Prior abdominal or pelvic surgery, aortic surgery (aortoenteric fistula risk), prior bowel resection
- Radiation history: Pelvic radiation for prostate, cervical, rectal, or bladder cancer causes chronic radiation proctitis
- Family history: Colorectal cancer, inflammatory bowel disease, polyposis syndromes, bleeding disorders
- Sexual history: Receptive anal intercourse may be associated with anorectal pathology; sexually transmitted proctitis
Quantifying Blood Loss
| Patient Description | Likely Volume | Clinical Significance |
|---|---|---|
| “Blood on the toilet paper” | Less than 5 mL | Likely anorectal source; often hemorrhoids or fissure |
| “Blood dripping into the bowl” | 5-30 mL | May be hemorrhoids or low rectal source; warrants examination |
| “Blood mixed with stool” or “bloody diarrhea” | Variable | Suggests colonic source; evaluate for colitis, malignancy, diverticular bleeding |
| “Bowl filled with blood” or “passing clots” | Greater than 100 mL per episode | Significant bleeding; requires urgent evaluation and likely admission |
| “Soaking through pads” or “needing to change clothes” | Greater than 500 mL | Major hemorrhage; assess for hemodynamic instability; urgent intervention needed |
Important Consideration: Upper Gastrointestinal Source
Remember that 10-15% of patients presenting with hematochezia actually have an upper gastrointestinal source, particularly if bleeding is brisk. Always ask about symptoms suggestive of upper gastrointestinal pathology: hematemesis, coffee-ground vomiting, epigastric pain, NSAID use, known peptic ulcer disease, liver disease, or recent retching/vomiting (Mallory-Weiss tear). A nasogastric tube aspirate or upper endoscopy may be indicated in patients with hemodynamically significant hematochezia, especially if the blood is dark or maroon-colored.
4. Physical Examination
A systematic approach for lower gastrointestinal bleeding
Systematic Framework: Use the “Resuscitation First, Then Head to Perineum” approach for complete examination of patients presenting with lower gastrointestinal bleeding. The initial focus must be on hemodynamic assessment and resuscitation, followed by systematic examination to identify the bleeding source and underlying etiology.
General Inspection
- Level of consciousness: Confusion, agitation, or lethargy may indicate significant hypovolemia or hypoperfusion
- Skin color and perfusion: Pallor suggests anemia; diaphoresis and cool extremities indicate shock
- Respiratory effort: Tachypnea may be compensatory response to anemia or acidosis
- General nutritional status: Cachexia or significant weight loss raises concern for malignancy
- Visible distress: Writhing pain suggests ischemia; calm patient with significant bleeding suggests diverticular or vascular source
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Tachycardia (greater than 100 beats per minute); note if on beta-blockers which may blunt response | Early sign of hypovolemia; heart rate greater than 100 suggests blood loss greater than 15% of blood volume |
| Blood Pressure | Hypotension (systolic less than 90 mmHg); narrowed pulse pressure; orthostatic changes | Hypotension indicates blood loss greater than 30-40%; orthostatic drop (systolic decrease greater than 20 mmHg on standing) suggests 15-20% loss |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Compensatory response to decreased oxygen-carrying capacity; may indicate metabolic acidosis from hypoperfusion |
| Temperature | Fever (greater than 38°C) or hypothermia | Fever suggests infectious colitis, inflammatory bowel disease, or ischemic colitis with necrosis; hypothermia may indicate severe shock |
| Oxygen Saturation | Desaturation (less than 94% on room air) | May be normal despite significant anemia (saturation measures percentage of hemoglobin saturated, not total oxygen content) |
| Shock Index | Heart rate divided by systolic blood pressure; greater than 1.0 is abnormal | Shock index greater than 1.0 associated with severe bleeding, need for transfusion, and higher mortality; useful for risk stratification |
Orthostatic Vital Signs
Perform orthostatic vital signs in stable patients: measure blood pressure and heart rate supine, then after standing for 2-3 minutes. A positive test (systolic blood pressure drop greater than 20 mmHg, diastolic drop greater than 10 mmHg, or heart rate increase greater than 30 beats per minute) suggests blood volume loss of 15-20% (approximately 750-1000 mL). However, do not perform in patients who are already hypotensive, symptomatic, or at risk of falling.
Skin and Peripheral Signs
Signs of Blood Loss
- Pallor: Check conjunctivae, palmar creases, nail beds; suggests hemoglobin less than 9-10 g/dL
- Capillary refill: Greater than 3 seconds suggests poor perfusion
- Skin turgor: Decreased in dehydration/hypovolemia
- Diaphoresis: Cold, clammy skin indicates sympathetic activation from shock
Signs Suggesting Underlying Etiology
- Purpura or petechiae: Coagulopathy, thrombocytopenia, vasculitis
- Spider angiomata, jaundice: Chronic liver disease with portal hypertension
- Erythema nodosum, pyoderma gangrenosum: Inflammatory bowel disease
- Acanthosis nigricans: May be associated with gastrointestinal malignancy
- Dermatitis herpetiformis: Celiac disease association
Abdominal Examination
Inspection
- Distension: May indicate obstruction, ileus, or massive colonic bleeding
- Surgical scars: Prior surgery may suggest adhesions, anastomotic issues, or identify previous pathology
- Caput medusae: Portal hypertension; consider portal hypertensive colopathy or rectal varices
- Visible peristalsis: May indicate obstruction
Auscultation
- Hyperactive bowel sounds: Blood is cathartic; increased peristalsis with active bleeding
- Absent bowel sounds: Suggests ileus, peritonitis, or ischemia with infarction
- High-pitched or tinkling sounds: May indicate mechanical obstruction
Palpation
- Tenderness location: Right lower quadrant (cecal pathology, appendicitis); left lower quadrant (diverticulitis, sigmoid pathology); generalized (colitis, peritonitis)
- Peritoneal signs: Guarding, rigidity, rebound tenderness indicate peritonitis—urgent surgical consultation needed
- Masses: Palpable abdominal mass raises concern for malignancy, abscess, or intussusception
- Hepatomegaly: Liver disease, metastatic disease
- Splenomegaly: Portal hypertension
Percussion
- Tympany: Air-filled bowel; excessive tympany with distension suggests obstruction or ileus
- Dullness: Shifting dullness indicates ascites (portal hypertension, malignancy)
- Loss of liver dullness: May indicate free intraperitoneal air (perforation)
Digital Rectal Examination
Essential Component of Assessment
Digital rectal examination is mandatory in all patients presenting with lower gastrointestinal bleeding. It provides crucial information about stool color, anorectal pathology, and rectal masses. The examination should assess the perianal area, anal canal, and rectum systematically.
| Component | What to Assess | Clinical Significance |
|---|---|---|
| Perianal inspection | External hemorrhoids, skin tags, fissures, fistula openings, condylomata, ulceration, masses | May identify anorectal source; thrombosed external hemorrhoid; fissure typically posterior midline |
| Anal tone | Resting and squeeze tone | Decreased tone may indicate neurological pathology or chronic prolapse; important for surgical planning |
| Anal canal | Internal hemorrhoids, polyps, masses, stricture, tenderness | Internal hemorrhoids not palpable unless thrombosed; low rectal tumors may be palpable |
| Rectal mucosa | Masses, polyps, ulceration, irregularity | Rectal cancer palpable in approximately 40-80% of cases depending on location; assess fixation and circumferential involvement |
| Stool on glove | Color: bright red, maroon, melenic (black tarry), normal brown; presence of mucus or pus | Fresh blood suggests active bleeding or distal source; melena suggests upper or proximal small bowel source |
| Prostate (males) | Size, nodules, tenderness | Prostate cancer may invade rectum; prostatic pathology important for radiation history assessment |
| Rectovaginal septum (females) | Masses, tenderness, nodularity | Gynecologic malignancy involving rectum; endometriosis |
Cardiovascular Examination
- Jugular venous pressure: Low JVP indicates hypovolemia; elevated JVP suggests heart failure or fluid overload from resuscitation
- Heart sounds: Ejection systolic murmur of aortic stenosis (Heyde syndrome association with angiodysplasia); flow murmur from anemia
- Peripheral pulses: Weak or absent pulses may indicate peripheral vascular disease (ischemic colitis risk factor)
- Atrial fibrillation: Risk factor for mesenteric ischemia; patient may be on anticoagulation
- Peripheral edema: Heart failure, hypoalbuminemia from chronic disease or malnutrition
Expected Findings by Etiology
| Condition | General Appearance | Abdominal Findings | Rectal Examination |
|---|---|---|---|
| Diverticular bleeding | May appear well or show signs of significant blood loss; typically no distress unless massive bleeding | Usually soft, non-tender; may have mild left lower quadrant tenderness if diverticulitis coexists | Maroon or bright red blood; no mass; may have blood clots |
| Ischemic colitis | Distress, may appear ill; signs of cardiovascular disease | Mild-moderate tenderness, often left-sided; peritoneal signs if transmural necrosis | Blood mixed with stool; may have mucus; tenderness on examination |
| Inflammatory bowel disease | May have extraintestinal manifestations; cachexia in chronic disease | Tenderness corresponding to affected segment; may have mass (abscess, phlegmon in Crohn disease) | Bloody mucus; perianal disease common in Crohn disease (fistulae, abscesses, skin tags) |
| Colorectal malignancy | Weight loss, cachexia in advanced disease; may appear well in early disease | May have palpable mass; hepatomegaly if metastatic; ascites in advanced disease | May palpate rectal mass; blood often mixed with stool; may have mucus |
| Hemorrhoids | Generally well-appearing; no signs of significant blood loss | Normal abdominal examination | External hemorrhoids visible; internal hemorrhoids seen on anoscopy; bright red blood on glove |
| Angiodysplasia | Pallor if chronic anemia; may have signs of aortic stenosis | Usually normal; no tenderness | Blood on glove; no mass; examination often normal |
| Infectious colitis | Fever, signs of dehydration; may appear toxic if severe | Diffuse or localized tenderness; hyperactive bowel sounds | Bloody diarrhea, possibly mucus or pus; tenderness may be present |
Important Teaching Point
Physical examination may be normal in many causes of lower gastrointestinal bleeding. Diverticular bleeding, angiodysplasia, post-polypectomy bleeding, and even early colorectal malignancy often present with completely normal abdominal and rectal examinations (except for blood on the glove). A normal examination does not exclude significant pathology and should not delay appropriate investigation. Conversely, the presence of peritoneal signs, hemodynamic instability, or a palpable mass requires urgent intervention. The rectal examination, while often normal, remains essential to assess stool color, exclude low rectal pathology, and occasionally identify an unexpected finding such as a rectal mass.
Anoscopy and Proctoscopy
| Examination | What It Visualizes | When to Perform |
|---|---|---|
| Anoscopy | Anal canal and distal rectum (approximately 6 cm); internal hemorrhoids, fissures, low rectal lesions | When anorectal source suspected; should be performed in most patients with bright red blood per rectum |
| Rigid proctoscopy | Rectum up to approximately 20-25 cm; rectal pathology, proctitis, low rectal tumors | When rectal pathology suspected; useful for assessing rectal bleeding source; can be performed at bedside |
| Flexible sigmoidoscopy | Rectum and sigmoid colon (up to approximately 60 cm); can assess left colon without full preparation | When left-sided pathology suspected; useful in limited preparation or unstable patients when full colonoscopy not possible |
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of lower gastrointestinal bleeding is broad, but a systematic approach based on patient age, bleeding severity, and associated clinical features allows efficient narrowing of possibilities. The causes can be organized anatomically (colonic versus small bowel versus anorectal), by probability (common versus uncommon), or by mechanism. In clinical practice, a probability-based approach is most useful, as it guides the sequence of investigation and ensures that common, treatable causes are not overlooked while serious conditions are appropriately excluded.
Acute Lower Gastrointestinal Bleeding
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70-80%) | Diverticular bleeding | Sudden, painless, large-volume maroon or bright red blood; often self-limited; age greater than 50; known diverticulosis | Hemodynamic instability; ongoing bleeding despite resuscitation |
| Hemorrhoidal bleeding | Bright red blood on paper or dripping; associated with straining; painless unless thrombosed; recurrent episodes | Rarely causes significant blood loss; if anemic, search for other source | |
| Ischemic colitis | Sudden crampy left-sided pain followed by bloody diarrhea; older patient; vascular risk factors; recent hypotension or surgery | Peritoneal signs; fever; acidosis (suggest transmural necrosis) | |
| LESS COMMON (approximately 15-20%) | Colonic angiodysplasia | Recurrent episodes; chronic anemia; older patient; aortic stenosis; renal failure; von Willebrand disease | Refractory anemia despite iron supplementation |
| Post-polypectomy bleeding | Bleeding 1-14 days after colonoscopy with polypectomy; peak days 5-7; larger polyps higher risk | Large volume bleeding; hemodynamic instability | |
| Colorectal malignancy | Change in bowel habits; weight loss; blood mixed with stool; iron deficiency anemia; age greater than 50 | Weight loss; palpable mass; family history; obstruction symptoms | |
| Inflammatory bowel disease | Bloody diarrhea with mucus; abdominal cramping; tenesmus; extraintestinal manifestations; younger patient | Toxic megacolon; severe systemic symptoms; failure to respond to therapy | |
| UNCOMMON BUT SERIOUS (approximately 5-10%) | Massive upper gastrointestinal bleeding | Brisk upper gastrointestinal bleeding presenting as hematochezia; hemodynamic instability; may have hematemesis | Shock; rapid transit suggests massive hemorrhage |
| Mesenteric ischemia (acute) | Severe abdominal pain out of proportion to examination; bloody diarrhea late finding; atrial fibrillation; cardiovascular disease | Pain out of proportion; acidosis; peritoneal signs | |
| Aortoenteric fistula | Prior aortic surgery; herald bleed followed by massive hemorrhage; abdominal or back pain | Prior aortic graft; any bleeding in this context is aortoenteric fistula until proven otherwise |
Chronic or Recurrent Lower Gastrointestinal Bleeding
Step-by-Step Approach to Chronic Lower Gastrointestinal Bleeding:
- Step 1: Rule out anorectal sources — hemorrhoids, fissures, rectal pathology (examination and anoscopy/proctoscopy)
- Step 2: Exclude colorectal malignancy — colonoscopy is mandatory in patients over 45-50 or with red flag symptoms
- Step 3: Investigate the “Big Three” colonic causes — diverticulosis, angiodysplasia, and neoplasia account for most cases
- Step 4: Consider small bowel sources if colonoscopy negative — capsule endoscopy, CT or MR enterography
- Step 5: Investigate obscure causes if standard workup negative — repeat endoscopy, deep enteroscopy, angiography
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Hemorrhoids | Very common source of minor bleeding | Bright red blood on paper; associated with straining; perianal symptoms; rarely causes anemia |
| Colorectal adenomas and polyps | 10-20% of chronic bleeding | Often occult bleeding; larger polyps more likely to bleed; villous histology higher risk | |
| Colorectal adenocarcinoma | 10-15% of chronic bleeding | Iron deficiency anemia; change in bowel habits; weight loss; right-sided tumors more occult | |
| Colonic angiodysplasia | 5-10% of chronic bleeding | Recurrent episodes; often elderly; associated with aortic stenosis, renal failure | |
| LESS COMMON | Inflammatory bowel disease | 5-10% | Chronic bloody diarrhea; mucus; cramping; extraintestinal manifestations; bimodal age distribution |
| Radiation proctitis or enteritis | Variable (history dependent) | History of pelvic radiation; chronic rectal bleeding; telangiectasias on endoscopy | |
| Solitary rectal ulcer syndrome | Rare | Straining; mucus discharge; sensation of incomplete evacuation; anterior rectal wall ulcer | |
| Small bowel angiodysplasia | 5% (higher if colonoscopy negative) | Iron deficiency anemia; negative upper and lower endoscopy; identified by capsule endoscopy | |
| UNCOMMON | Meckel diverticulum | Rare in adults; more common cause in young adults | Painless bleeding in young patient; contains ectopic gastric mucosa; positive Meckel scan |
| Small bowel tumors | 1-2% | Gastrointestinal stromal tumor, carcinoid, adenocarcinoma, lymphoma; often found on capsule or CT enterography | |
| Dieulafoy lesion | Rare | Massive bleeding from submucosal artery; can occur anywhere in gastrointestinal tract; difficult to diagnose | |
| Portal hypertensive colopathy and rectal varices | Rare (in portal hypertension) | Known cirrhosis; portal hypertension stigmata; colonoscopy shows varices or colopathy |
Anatomical Approach to Lower Gastrointestinal Bleeding
Anorectal Sources
Hemorrhoids (internal and external)
Anal fissure
Rectal cancer
Rectal polyps
Radiation proctitis
Solitary rectal ulcer syndrome
Rectal varices
Proctitis (infectious, inflammatory bowel disease)
Colonic Sources
Diverticulosis and diverticular bleeding
Colonic angiodysplasia
Colorectal adenocarcinoma
Colorectal polyps
Ischemic colitis
Inflammatory bowel disease
Infectious colitis
Portal hypertensive colopathy
Small Bowel Sources
Small bowel angiodysplasia
Meckel diverticulum
Small bowel tumors (gastrointestinal stromal tumor, carcinoid, adenocarcinoma)
Crohn disease
NSAID-induced enteropathy
Small bowel ulcers
Aortoenteric fistula
Upper Gastrointestinal Sources (Presenting as Hematochezia)
Peptic ulcer disease (massive bleeding)
Esophageal or gastric varices
Gastric cancer
Dieulafoy lesion
Mallory-Weiss tear
Erosive gastritis
Drug-Induced and Iatrogenic Lower Gastrointestinal Bleeding
| Drug or Cause | Mechanism | Characteristics | Management Considerations |
|---|---|---|---|
| Nonsteroidal anti-inflammatory drugs | Prostaglandin inhibition causes mucosal injury; platelet dysfunction impairs hemostasis; can cause colonic ulceration and diaphragm disease | Can cause or exacerbate bleeding from any source; enteropathy with small bowel ulcers and strictures | Discontinue NSAID; consider COX-2 selective if anti-inflammatory needed; add proton pump inhibitor |
| Aspirin | Irreversible cyclooxygenase inhibition; impairs platelet aggregation for platelet lifespan (7-10 days) | Increases bleeding risk from any source; particularly problematic with concurrent anticoagulation | Risk-benefit assessment; may need to continue for high cardiovascular risk; platelet transfusion if severe bleeding |
| Clopidogrel, prasugrel, ticagrelor | P2Y12 receptor inhibition prevents platelet activation and aggregation | Higher bleeding risk than aspirin alone; dual antiplatelet therapy significantly increases risk | Consult cardiology before stopping post-stent; platelet transfusion may have limited efficacy |
| Warfarin | Vitamin K antagonist; inhibits synthesis of factors II, VII, IX, X | Supratherapeutic INR markedly increases risk; therapeutic INR still increases bleeding from existing lesions | Hold warfarin; vitamin K (oral or intravenous); prothrombin complex concentrate or fresh frozen plasma if severe |
| Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban) | Direct factor Xa inhibition (apixaban, rivaroxaban, edoxaban) or direct thrombin inhibition (dabigatran) | Lower intracranial bleeding risk than warfarin but gastrointestinal bleeding risk similar or higher | Hold medication; idarucizumab reverses dabigatran; andexanet alfa reverses factor Xa inhibitors; prothrombin complex concentrate may help |
| Post-polypectomy bleeding | Eschar sloughing from polypectomy site exposing underlying vessels; typically days 5-7 post-procedure | Risk increases with polyp size (greater than 2 cm), sessile morphology, right colon location, anticoagulation | Repeat colonoscopy with endoscopic hemostasis (clips, thermal therapy); rarely requires angiography or surgery |
| Post-biopsy bleeding | Direct trauma to mucosal vessels during biopsy | Usually minor and self-limited; higher risk with coagulopathy or anticoagulation | Usually self-limited; endoscopic therapy if significant |
| Radiation-induced bleeding | Chronic radiation injury causes obliterative endarteritis and mucosal telangiectasia; typically months to years after radiation | Chronic rectal bleeding; telangiectasia on endoscopy; may have stricture; history of pelvic radiation | Argon plasma coagulation; formalin application; hyperbaric oxygen; sucralfate enemas; surgery for refractory cases |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Painless large-volume maroon blood in elderly patient | Diverticular bleeding | Resuscitate; colonoscopy when stable and prepared |
| Sudden crampy abdominal pain then bloody diarrhea | Ischemic colitis | CT abdomen with contrast; surgical consultation if peritoneal signs |
| Bright red blood on toilet paper with straining | Hemorrhoids or anal fissure | Examination with anoscopy; colonoscopy if over 45-50 or red flags |
| Chronic bloody diarrhea with mucus in young patient | Inflammatory bowel disease | Colonoscopy with biopsies; stool studies to exclude infection |
| Iron deficiency anemia with occult blood positive stool | Colorectal malignancy until proven otherwise | Colonoscopy; consider upper endoscopy if colonoscopy negative |
| Recurrent bleeding in patient with aortic stenosis | Angiodysplasia (Heyde syndrome) | Colonoscopy; consider capsule endoscopy for small bowel; check von Willebrand factor activity |
| Bleeding 1 week after colonoscopy with polypectomy | Post-polypectomy bleeding | Repeat colonoscopy for endoscopic hemostasis |
| Prior aortic graft with any gastrointestinal bleeding | Aortoenteric fistula until proven otherwise | CT angiography; emergent surgical consultation; do not delay for endoscopy |
| Massive hematochezia with hemodynamic instability | Consider upper gastrointestinal source (10-15%) | Resuscitate; upper endoscopy before or with colonoscopy; nasogastric aspirate may help localize |
| Painless bleeding in young adult with negative colonoscopy | Meckel diverticulum | Technetium-99m pertechnetate scan; consider CT enterography or capsule endoscopy |
| Chronic rectal bleeding with pelvic radiation history | Radiation proctitis | Proctoscopy or flexible sigmoidoscopy; argon plasma coagulation for telangiectasia |
6. Diagnostic Investigations
A stepwise, evidence-based approach guided by clinical presentation and severity
The investigation of lower gastrointestinal bleeding should be guided by the acuity and severity of bleeding, hemodynamic status, and clinical suspicion for specific etiologies. In acute significant bleeding, the priority is resuscitation and stabilization before definitive investigation. Colonoscopy remains the primary diagnostic and therapeutic modality for most cases, but the timing and preparation depend on bleeding severity. For patients with hemodynamically significant bleeding or when colonoscopy is non-diagnostic, additional modalities including CT angiography, nuclear medicine bleeding scans, and angiography may be required.
Baseline Laboratory Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Assess severity of blood loss and baseline values | Hemoglobin, hematocrit; note that acute bleeding may not show immediate hemoglobin drop; platelet count for hemostasis | Hemoglobin may take 24-72 hours to equilibrate after acute bleeding; serial measurements essential; MCV low in chronic bleeding |
| Coagulation studies (PT/INR, aPTT) | Identify coagulopathy; guide reversal if on anticoagulation | Prolonged INR in warfarin use or liver disease; aPTT prolonged with heparin or intrinsic pathway disorders | Direct oral anticoagulants may not significantly affect standard coagulation tests; specific assays available |
| Type and screen (or crossmatch) | Prepare for potential transfusion | Blood type; antibody screen for safe transfusion | Crossmatch if active significant bleeding; maintain 2-4 units available for massive transfusion protocol |
| Basic metabolic panel | Assess renal function, electrolytes, hydration status | Elevated BUN:creatinine ratio (greater than 20:1) suggests upper gastrointestinal or absorbed blood; hypokalemia common with diarrhea | BUN may rise from absorbed nitrogenous blood products; creatinine elevation may reflect hypovolemia |
| Liver function tests | Assess for liver disease as etiology or comorbidity | Elevated bilirubin, low albumin, prolonged PT suggest cirrhosis; consider portal hypertensive bleeding | Chronic liver disease associated with coagulopathy, portal hypertensive colopathy, rectal varices |
| Lactate | Assess tissue perfusion; identify ischemia | Elevated lactate (greater than 2 mmol/L) suggests hypoperfusion or intestinal ischemia | Marked elevation (greater than 4 mmol/L) with abdominal pain highly suspicious for mesenteric ischemia |
| Iron studies | Identify chronic blood loss | Low ferritin, low iron, elevated TIBC indicate iron deficiency from chronic bleeding | Ferritin may be falsely normal or elevated if acute inflammation; check in stable patients with suspected chronic bleeding |
Imaging Investigations
| Modality | When to Use | What It Shows | Advantages and Limitations |
|---|---|---|---|
| CT abdomen and pelvis with intravenous contrast | Hemodynamically unstable patients; suspected ischemia, perforation, or mass; when colonoscopy cannot be performed urgently | Active extravasation (arterial phase); bowel wall thickening; masses; diverticulosis; signs of ischemia (pneumatosis, portal venous gas) | Rapid, widely available; can identify source and guide intervention; cannot treat bleeding; radiation exposure; requires contrast |
| CT angiography | Active significant bleeding when colonoscopy not feasible; to localize source before angiographic intervention | Active contrast extravasation (detects bleeding greater than 0.3-0.5 mL/min); vascular anatomy for intervention planning | More sensitive than standard CT for active bleeding; guides angiographic intervention; requires active bleeding at time of scan |
| Tagged red blood cell scan (nuclear medicine) | Intermittent or slow bleeding when CT angiography and colonoscopy negative; can detect bleeding as slow as 0.1 mL/min | Accumulation of radiolabeled red cells at bleeding site over time (can image for up to 24 hours) | Most sensitive for slow intermittent bleeding; localizes to region (not precise); cannot treat; requires nuclear medicine availability |
| Mesenteric angiography | Massive ongoing bleeding when source localized by CT angiography; when colonoscopic hemostasis fails or not possible | Active contrast extravasation (requires bleeding greater than 0.5-1.0 mL/min); vascular abnormalities; therapeutic embolization possible | Diagnostic and therapeutic; can embolize bleeding vessel; invasive; risk of bowel ischemia from embolization; requires interventional radiology |
| Abdominal radiograph | Limited role; suspected obstruction or perforation | Free air (perforation); dilated bowel (obstruction or toxic megacolon); thumbprinting in ischemic colitis | Quick, low cost; limited sensitivity; largely replaced by CT for acute assessment |
| Meckel scan (technetium-99m pertechnetate) | Suspected Meckel diverticulum, particularly in young patients with painless rectal bleeding | Uptake by ectopic gastric mucosa in Meckel diverticulum | Sensitivity 85% in children, lower in adults; pretreatment with H2 blocker or proton pump inhibitor may improve detection; false negatives if no gastric mucosa |
Endoscopic Investigations
Colonoscopy
Indications and Timing
- Primary diagnostic modality for lower gastrointestinal bleeding
- Urgent colonoscopy (within 24 hours): Recommended for hemodynamically significant bleeding after resuscitation and bowel preparation
- Early colonoscopy (within 24-48 hours): For moderate bleeding; allows diagnostic yield and potential therapy
- Elective colonoscopy: For minor self-limited bleeding or chronic occult bleeding
- Preparation: Rapid bowel preparation with polyethylene glycol (4-6 L over 3-4 hours) preferred; preparation improves diagnostic yield and safety
Therapeutic Capabilities
- Endoscopic clips: Mechanical hemostasis for diverticular bleeding, post-polypectomy bleeding, visible vessels
- Thermal coagulation: Bipolar cautery, heater probe for angiodysplasia, bleeding lesions
- Argon plasma coagulation: Non-contact thermal therapy for angiodysplasia, radiation proctitis
- Injection therapy: Epinephrine injection for temporary hemostasis (usually combined with other methods)
- Hemostatic powders and gels: Topical agents for diffuse bleeding or when other methods fail
Upper Endoscopy (Esophagogastroduodenoscopy)
When to Perform Upper Endoscopy in Lower Gastrointestinal Bleeding
Approximately 10-15% of patients presenting with hematochezia have an upper gastrointestinal source. Consider upper endoscopy before or concurrently with colonoscopy when:
- Hemodynamic instability or massive bleeding (rapid transit from upper source)
- Elevated BUN:creatinine ratio greater than 30:1 (suggests absorbed blood)
- Nasogastric aspirate with blood or coffee grounds (though negative aspirate does not exclude duodenal source)
- History of peptic ulcer disease, liver disease, or prior upper gastrointestinal bleeding
- Melena or dark maroon blood suggesting proximal source
- Colonoscopy negative and bleeding continues
Additional Endoscopic Modalities
| Modality | When to Use | What It Shows | Practical Points |
|---|---|---|---|
| Flexible sigmoidoscopy | Limited preparation available; suspected distal colonic or rectal source; bedside assessment in unstable patients | Rectum and sigmoid colon (up to 60 cm); can identify anorectal pathology, left-sided bleeding sources | Does not require full bowel preparation; misses right-sided pathology; useful as initial assessment |
| Video capsule endoscopy | Obscure gastrointestinal bleeding (negative upper endoscopy and colonoscopy); suspected small bowel source | Small bowel mucosa from duodenum to terminal ileum; angiodysplasia, tumors, ulcers, Crohn disease | Non-invasive; diagnostic only (cannot treat); risk of capsule retention in strictures; requires bowel preparation |
| Device-assisted enteroscopy (balloon enteroscopy) | Therapeutic intervention for small bowel lesions identified on capsule endoscopy; small bowel bleeding source localized | Allows deep small bowel visualization with therapeutic capability | Can reach most of small bowel with antegrade and retrograde approaches; allows biopsy and treatment; requires specialized expertise |
| Anoscopy and rigid proctoscopy | Suspected anorectal pathology; evaluation of hemorrhoids, fissures, low rectal lesions | Anal canal and distal rectum; internal hemorrhoids, fissures, rectal masses | Can be performed at bedside without preparation; complements digital rectal examination |
Targeted Investigations by Suspected Etiology
If Suspecting Diverticular Bleeding
First-Line Tests
- Colonoscopy: Gold standard; identifies diverticula and may show active bleeding or stigmata (visible vessel, adherent clot); allows therapeutic intervention
- CT abdomen: Shows diverticulosis; CT angiography may show active extravasation if bleeding brisk
Second-Line Tests
- Mesenteric angiography: When colonoscopy cannot localize source and bleeding ongoing; allows embolization
- Tagged red blood cell scan: For intermittent bleeding to localize before intervention
If Suspecting Colorectal Malignancy
First-Line Tests
- Colonoscopy with biopsy: Definitive diagnostic test; allows tissue diagnosis and tattooing for surgical localization
- Complete blood count with iron studies: Microcytic anemia supports chronic blood loss
Staging Tests (if malignancy confirmed)
- CT chest, abdomen, and pelvis: Staging for metastatic disease
- MRI pelvis: For rectal cancer staging (T and N stage)
- Carcinoembryonic antigen (CEA): Baseline for monitoring; prognostic value
If Suspecting Inflammatory Bowel Disease
First-Line Tests
- Colonoscopy with biopsies: Assess extent and severity; histological confirmation; multiple biopsies throughout colon
- Stool studies: Culture, Clostridioides difficile toxin, ova and parasites to exclude infectious colitis
- Fecal calprotectin: Elevated in active inflammatory bowel disease (greater than 250 μg/g suggests active inflammation)
Second-Line Tests
- MR or CT enterography: For suspected small bowel Crohn disease; assesses strictures, fistulae
- Upper endoscopy: If Crohn disease suspected, assess for upper gastrointestinal involvement
- Capsule endoscopy: Small bowel assessment when enterography inconclusive
If Suspecting Ischemic Colitis
First-Line Tests
- CT abdomen with intravenous contrast: Shows bowel wall thickening, thumbprinting, pericolonic stranding; excludes perforation; assesses for pneumatosis or portal venous gas (indicating severe ischemia)
- Lactate: Elevated suggests severe ischemia or necrosis
Second-Line Tests
- Colonoscopy or flexible sigmoidoscopy: When patient stable; shows mucosal changes (edema, hemorrhage, ulceration); biopsy for confirmation; determines extent
- CT angiography or mesenteric angiography: If mesenteric arterial occlusion suspected (severe pain, systemic toxicity)
If Suspecting Small Bowel Source
First-Line Tests
- Video capsule endoscopy: First-line test for obscure gastrointestinal bleeding after negative upper endoscopy and colonoscopy; diagnostic yield 40-60%
- CT or MR enterography: Identifies tumors, Crohn disease, structural abnormalities
Second-Line Tests
- Device-assisted enteroscopy: For therapeutic intervention or biopsy of identified lesions
- Meckel scan: If Meckel diverticulum suspected (young patient, painless bleeding)
- Intraoperative enteroscopy: Last resort for refractory obscure bleeding
Investigation Algorithm by Bleeding Severity
Severe or Massive Bleeding (Hemodynamically Unstable):
- Resuscitation: Large-bore intravenous access, fluid resuscitation, blood products as needed
- Laboratory tests: Complete blood count, coagulation studies, type and crossmatch, lactate
- Consider upper endoscopy if unclear source or massive hematochezia (exclude upper gastrointestinal source)
- CT angiography if hemodynamically unstable or colonoscopy not feasible
- Urgent colonoscopy after resuscitation and rapid bowel preparation if stabilized
- Mesenteric angiography with embolization if active bleeding identified on CT angiography
- Surgical consultation for ongoing hemodynamic instability or failed intervention
Moderate Bleeding (Hemodynamically Stable):
- Admit for observation and resuscitation as needed
- Laboratory tests and blood typing
- Bowel preparation for colonoscopy
- Colonoscopy within 24 hours of presentation
- Upper endoscopy if colonoscopy non-diagnostic and suspicion for upper source
- CT angiography if bleeding recurs before or during preparation
Minor or Occult Bleeding:
- Outpatient evaluation appropriate if no red flags
- Complete blood count and iron studies
- Colonoscopy as elective procedure (within 2-4 weeks)
- Upper endoscopy if iron deficiency anemia and colonoscopy normal
- Consider capsule endoscopy if both upper and lower endoscopy negative
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for lower gastrointestinal bleeding
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Hemodynamic instability (systolic blood pressure less than 90 mmHg, heart rate greater than 120, or shock index greater than 1.0) | EMERGENT | Two large-bore intravenous lines; activate massive transfusion protocol; urgent surgical and gastroenterology consultation; consider CT angiography; intensive care unit admission |
| Peritoneal signs (guarding, rigidity, rebound tenderness) | EMERGENT | Emergent surgical consultation; CT abdomen; broad-spectrum antibiotics; likely requires emergency laparotomy |
| Prior aortic graft with any gastrointestinal bleeding | EMERGENT | Assume aortoenteric fistula until proven otherwise; emergent vascular surgery consultation; CT angiography; prepare for emergency surgery |
| Ongoing large-volume bleeding with dropping hemoglobin despite resuscitation | EMERGENT | Continue resuscitation; CT angiography for localization; interventional radiology for embolization or emergency surgery if source identified |
| Hemodynamically stable but significant bleeding (requiring transfusion or hemoglobin drop greater than 2 g/dL) | URGENT | Admit to monitored bed; resuscitate; bowel preparation; colonoscopy within 24 hours; surgical consultation |
| Moderate bleeding, stable vital signs, no red flags | URGENT | Admit for observation; laboratory tests and type and screen; colonoscopy within 24-48 hours after preparation |
| Minor self-limited bleeding, stable, no red flags | ROUTINE | Outpatient evaluation acceptable; elective colonoscopy within 2-4 weeks; earlier if age greater than 45-50 or red flags |
| Occult bleeding or iron deficiency anemia | ROUTINE | Outpatient colonoscopy; consider upper endoscopy if colonoscopy negative; iron supplementation |
Step 2: Risk Stratification
Oakland Score for Lower Gastrointestinal Bleeding
The Oakland Score helps identify patients with acute lower gastrointestinal bleeding who may be safely managed as outpatients. A score of 8 or less predicts greater than 95% probability of safe discharge.
Variables and Points:
- Age: 40-69 years (0), 70+ years (1)
- Sex: Female (0), Male (1)
- Previous lower gastrointestinal bleeding admission: No (0), Yes (1)
- Digital rectal examination: No blood (0), Blood present (1)
- Heart rate: Less than 70 (0), 70-89 (1), 90-109 (2), 110+ (3)
- Systolic blood pressure: 130+ (0), 120-129 (1), 110-119 (2), 100-109 (3), 90-99 (4), less than 90 (5)
- Hemoglobin: 130-159 g/L (0), 110-129 (2), 90-109 (4), 70-89 (6), less than 70 (10)
Interpretation:
- Score 8 or less: Low risk; consider outpatient management with elective colonoscopy
- Score 9-16: Moderate risk; admission for observation and colonoscopy within 24-48 hours
- Score greater than 16: High risk; admission, close monitoring, urgent intervention likely needed
Note: Clinical judgment should always supplement risk scores. Patients with red flags, concerning history, or social factors precluding safe outpatient follow-up should be admitted regardless of score.
Step 3: Follow the Appropriate Algorithm
Massive Bleeding
Greater than 4 units transfusion in 24 hours or persistent hemodynamic instability
Proceed to Algorithm A
Significant Bleeding
Hemoglobin drop greater than 2 g/dL, requiring transfusion, but hemodynamically responsive
Proceed to Algorithm B
Minor Bleeding
Self-limited, stable hemoglobin, no transfusion required
Proceed to Algorithm C
Algorithm A: Massive Lower Gastrointestinal Bleeding
| Clinical Scenario | Most Likely Approach | Action |
|---|---|---|
| Ongoing massive bleeding, source unknown | Localization then intervention | CT angiography to localize; if positive, proceed to angiographic embolization or surgery based on findings |
| CT angiography shows active extravasation | Angiographic embolization | Interventional radiology for selective embolization; surgical backup for failure or ischemia |
| CT angiography negative, bleeding continues | Tagged red blood cell scan or repeat CT angiography | Nuclear medicine scan may detect intermittent bleeding; repeat CT if rebleeds; consider emergent colonoscopy if stabilizes |
| Source localized to specific colonic segment, ongoing bleeding | Segmental colectomy | Surgical resection of involved segment with primary anastomosis or ostomy depending on stability |
| Source not localized despite all interventions, life-threatening bleeding | Subtotal colectomy | Last resort; high morbidity; indicated when source cannot be localized and bleeding is life-threatening |
Algorithm B: Significant Lower Gastrointestinal Bleeding (Hemodynamically Responsive)
| Clinical Scenario | Most Likely Approach | Action |
|---|---|---|
| Stable after initial resuscitation | Urgent colonoscopy | Rapid bowel preparation (4-6 L polyethylene glycol over 3-4 hours); colonoscopy within 24 hours |
| Colonoscopy identifies diverticular bleeding with stigmata | Endoscopic therapy | Endoscopic clips, thermal coagulation, or injection therapy; mark site with tattoo if surgery may be needed |
| Colonoscopy identifies angiodysplasia | Endoscopic ablation | Argon plasma coagulation or thermal coagulation; document location; may require repeat sessions |
| Colonoscopy identifies mass or polyp | Biopsy and staging | Biopsy for histology; complete staging workup; surgical resection for malignancy |
| Colonoscopy non-diagnostic, bleeding stopped | Observation and investigation | Consider upper endoscopy to exclude upper source; capsule endoscopy for small bowel if both negative |
| Rebleeding after colonoscopy | Repeat endoscopy or angiography | Repeat colonoscopy if source was identified; CT angiography if ongoing active bleeding |
Algorithm C: Minor Lower Gastrointestinal Bleeding
| Clinical Scenario | Most Likely Approach | Action |
|---|---|---|
| Bright red blood on paper only, young patient (less than 40), no red flags | Anorectal examination and conservative management | Digital rectal examination and anoscopy; treat hemorrhoids or fissure; colonoscopy if symptoms persist or red flags develop |
| Minor bleeding, age 45-50 or older, or any red flags | Colonoscopy | Elective colonoscopy within 2-4 weeks to exclude malignancy and identify source |
| Occult blood positive or iron deficiency anemia | Bidirectional endoscopy | Colonoscopy first; upper endoscopy if colonoscopy negative; capsule endoscopy for small bowel if both negative |
| Post-polypectomy bleeding (minor, self-limited) | Observation | If truly minor and self-limited, observation acceptable; repeat colonoscopy if bleeding recurs or is significant |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on warfarin with INR 4.5 and active bleeding | Hold warfarin; administer vitamin K 10 mg intravenously; prothrombin complex concentrate (or fresh frozen plasma if unavailable) | Discuss with cardiology regarding anticoagulation reversal risks; restart anticoagulation when bleeding controlled and clinically appropriate |
| Patient on dabigatran with active bleeding | Hold dabigatran; consider idarucizumab (Praxbind) 5 g intravenously for immediate reversal | Check thrombin time or ecarin clotting time if available; supportive care; hemodialysis may help remove drug |
| Patient on rivaroxaban or apixaban with active bleeding | Hold medication; consider andexanet alfa if available and life-threatening bleeding; otherwise prothrombin complex concentrate | Anti-Xa levels can assess drug activity; supportive care; drugs not dialyzable |
| Patient on dual antiplatelet therapy (aspirin and clopidogrel) with bleeding | Urgent cardiology consultation before stopping; weigh bleeding severity against stent thrombosis risk | If life-threatening bleeding, may need to stop; platelet transfusion may help aspirin but limited efficacy for P2Y12 inhibitors |
| Colonoscopy shows ischemic colitis without perforation | Bowel rest; intravenous fluids; broad-spectrum antibiotics; serial abdominal examinations | Repeat imaging or endoscopy if no improvement in 24-48 hours; surgery for peritonitis, perforation, or clinical deterioration |
| CT shows pneumatosis and portal venous gas | Emergent surgical consultation; these findings suggest transmural ischemia or necrosis | Emergency laparotomy; resection of nonviable bowel; damage control surgery if unstable |
| Diverticular bleeding stops spontaneously | Proceed with colonoscopy once prepared to identify and potentially treat the source | Document diverticular location; discuss elective surgical resection if recurrent bleeding from identified segment |
| Recurrent diverticular bleeding from same segment | Surgical consultation for elective segmental colectomy | After two or more episodes from same segment, risk of rebleeding is 50%; elective resection reduces rebleeding risk |
| Colonoscopy negative, upper endoscopy negative, bleeding continues | Consider small bowel source; proceed to capsule endoscopy or CT enterography | Device-assisted enteroscopy if lesion identified on capsule; Meckel scan in young patients; repeat endoscopy may find missed lesion |
| Patient refuses blood transfusion (for example, Jehovah’s Witness) | Respect patient autonomy; optimize hemostasis; use iron supplementation, erythropoietin; minimize blood draws | Document discussion clearly; aggressive endoscopic or surgical hemostasis may be needed earlier; cell salvage if acceptable to patient |
Troubleshooting Refractory Lower Gastrointestinal Bleeding
Ask These Questions When Bleeding Does Not Stop
- Is the source truly lower gastrointestinal? Consider upper endoscopy if not already done; 10-15% of hematochezia is from upper gastrointestinal source
- Has the small bowel been evaluated? Capsule endoscopy or CT enterography may reveal occult small bowel source
- Are there ongoing factors impairing hemostasis? Uncontrolled anticoagulation, coagulopathy, uremia, thrombocytopenia
- Was the correct source treated? Multiple pathology may coexist; treating one source does not exclude others
- Is this an unusual source? Consider Dieulafoy lesion, aortoenteric fistula, hemobilia, hemosuccus pancreaticus
- Was endoscopy adequate? Poor preparation or incomplete examination may miss lesions; consider repeat endoscopy
- Is surgical intervention indicated? When medical and endoscopic management fails, timely surgery may be life-saving
Indications for Surgical Consultation and Intervention
| Indication | Urgency | Likely Surgical Approach |
|---|---|---|
| Hemodynamic instability despite resuscitation | Emergent | Exploratory laparotomy; segmental or subtotal colectomy based on findings |
| Peritonitis or perforation | Emergent | Exploratory laparotomy; resection of affected bowel; washout; ostomy likely |
| Transmural ischemia (pneumatosis, portal venous gas) | Emergent | Exploratory laparotomy; resection of nonviable bowel; second-look laparotomy often indicated |
| Aortoenteric fistula | Emergent | Emergent laparotomy with vascular surgery; graft excision and reconstruction or extra-anatomic bypass |
| Failure of angiographic embolization | Urgent | Segmental colectomy if source localized; subtotal colectomy if source unknown |
| Transfusion requirement greater than 6 units in 24 hours | Urgent | Surgical exploration; directed resection if source known |
| Recurrent diverticular bleeding from identified segment | Elective | Elective segmental colectomy (for example, right hemicolectomy or sigmoid colectomy) |
| Colorectal malignancy | Elective (urgent if obstructing or perforated) | Oncological resection with appropriate lymphadenectomy |
| Meckel diverticulum with bleeding | Elective to urgent | Meckel diverticulectomy or segmental ileal resection |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
10-15% of hematochezia is from an upper gastrointestinal source: Always consider upper endoscopy in patients with hemodynamically significant hematochezia, especially if blood is dark or maroon, there is hemodynamic instability, or the patient has risk factors for upper gastrointestinal bleeding.
Most lower gastrointestinal bleeding stops spontaneously: Approximately 80-85% of lower gastrointestinal bleeding episodes cease without intervention. However, this should not delay appropriate resuscitation, investigation, or preparation for potential intervention.
Right-sided diverticula bleed more than left-sided: Despite the majority of diverticula being in the sigmoid colon, right-sided diverticula are more prone to bleeding due to wider necks and larger penetrating arteries. Colonoscopic localization is essential before surgery.
Heyde syndrome is underdiagnosed: The triad of aortic stenosis, acquired von Willebrand syndrome, and angiodysplasia bleeding is more common than appreciated. Check for aortic murmur and consider von Willebrand factor testing in patients with recurrent angiodysplasia bleeding.
Prior aortic graft plus gastrointestinal bleeding equals aortoenteric fistula until proven otherwise: This life-threatening diagnosis must be actively excluded. CT angiography is the initial test of choice. Do not delay surgical consultation for endoscopy.
Ischemic colitis typically affects watershed areas: The splenic flexure (Griffiths point) and rectosigmoid junction (Sudeck point) are most vulnerable. Sudden crampy pain followed by bloody diarrhea in an elderly patient with vascular disease is classic.
Post-polypectomy bleeding peaks at days 5-7: Patients should be counseled about this risk before discharge. Bleeding occurs when the eschar at the polypectomy site sloughs. Larger polyps, right-sided location, and anticoagulation increase risk.
Colonoscopy with bowel preparation improves diagnostic yield and safety: Even in urgent situations, rapid bowel preparation improves visualization, allows accurate diagnosis, and enables safer therapeutic intervention. Unprepared colonoscopy has lower diagnostic yield and higher complication risk.
Critical Pitfalls to Avoid
Assuming all hematochezia is lower gastrointestinal bleeding: A brisk upper gastrointestinal bleed can present with bright red blood per rectum. Missing a bleeding peptic ulcer or variceal hemorrhage can be fatal.
Attributing bleeding to hemorrhoids without proper evaluation: While hemorrhoids are common, attributing significant or new bleeding to hemorrhoids without colonoscopy (especially in patients over 45-50 or with red flags) risks missing colorectal cancer.
Delaying colonoscopy because bleeding has stopped: Spontaneous cessation of bleeding does not eliminate the need for colonoscopy. The underlying lesion remains, and early colonoscopy improves diagnostic yield and may identify lesions requiring treatment.
Performing subtotal colectomy without attempting source localization: Subtotal colectomy carries significant morbidity and should be reserved for situations where the source truly cannot be localized despite appropriate investigations. Every effort should be made to identify and treat the source or perform segmental resection.
Forgetting to check hemoglobin serially: Initial hemoglobin may be normal or near-normal in acute bleeding before hemodilution occurs. Serial measurements (every 4-6 hours in active bleeding) are essential to assess the severity and trend of blood loss.
Over-relying on nasogastric aspirate to exclude upper gastrointestinal source: A negative or bilious nasogastric aspirate does not exclude a duodenal source. If clinical suspicion for upper gastrointestinal bleeding is high, proceed to upper endoscopy regardless of aspirate results.
Stopping anticoagulation without appropriate consultation: The decision to reverse or hold anticoagulation must balance bleeding risk against thromboembolic risk. Patients with mechanical heart valves or recent coronary stents are at high risk of catastrophic thrombosis. Always involve cardiology in these decisions.
Missing ischemic colitis progression to transmural necrosis: Non-gangrenous ischemic colitis is managed conservatively, but 15-20% progress to transmural necrosis requiring surgery. Serial abdominal examinations and repeat imaging are essential. Peritoneal signs, fever, leukocytosis, or rising lactate should prompt urgent surgical intervention.
Key Takeaways
- Lower gastrointestinal bleeding accounts for 20-25% of gastrointestinal hemorrhage; mortality is 2-4% overall but rises to 10-20% in hospitalized patients with comorbidities
- The most common causes are diverticulosis (30-40%), hemorrhoids, angiodysplasia, ischemic colitis, and colorectal neoplasia
- Always consider upper gastrointestinal source in significant hematochezia (10-15% of cases are upper gastrointestinal bleeding)
- Hemodynamic assessment and resuscitation take priority; use shock index (heart rate divided by systolic blood pressure greater than 1.0 is abnormal) for rapid assessment
- Colonoscopy is the primary diagnostic and therapeutic modality; bowel preparation improves yield and safety even in urgent situations
- CT angiography is valuable for unstable patients or when colonoscopy is not feasible; can guide angiographic intervention
- Risk stratification tools like the Oakland Score help identify patients suitable for outpatient management
- Anticoagulation management requires balancing bleeding risk against thromboembolic risk; involve cardiology for high-risk patients
- Most lower gastrointestinal bleeding (80-85%) stops spontaneously, but investigation is still needed to identify the source
- Recurrent diverticular bleeding from an identified segment may warrant elective surgical resection
- Surgical intervention is indicated for hemodynamic instability despite resuscitation, peritonitis, transmural ischemia, or failure of endoscopic and angiographic management
- Prior aortic graft with any gastrointestinal bleeding must be treated as aortoenteric fistula until proven otherwise
Quick Reference Algorithm
Systematic Approach to Lower Gastrointestinal Bleeding:
- Assess and resuscitate: Airway, breathing, circulation; two large-bore intravenous lines; fluid resuscitation; blood products as needed; oxygen supplementation
- Risk stratify: Determine urgency based on hemodynamic status, vital signs, shock index, and risk scores (Oakland Score); identify red flags requiring emergent intervention
- Exclude upper gastrointestinal source: Consider upper endoscopy before or with colonoscopy if hemodynamically significant bleeding, dark blood, or upper gastrointestinal risk factors
- Localize and diagnose: Colonoscopy after rapid bowel preparation for stable patients; CT angiography for unstable patients or when colonoscopy not feasible; tagged red blood cell scan for intermittent bleeding
- Treat the source: Endoscopic therapy (clips, thermal coagulation, argon plasma coagulation) for identified lesions; angiographic embolization for ongoing bleeding localized by CT angiography; surgical resection for failed intervention or anatomical necessity
- Manage anticoagulation: Assess indication and risk; reverse if life-threatening bleeding; consult cardiology for high-risk patients; plan resumption when bleeding controlled
- Plan follow-up: Address underlying etiology; surveillance for neoplasia; discuss surgical options for recurrent diverticular bleeding; optimize modifiable risk factors